Investors File Class Action Lawsuit Against Hims & Hers Health
Shareholders have until November 2, 2026, to file as lead plaintiffs in a class action lawsuit against Hims & Hers Health, Inc. concerning alleged misstatements during the 2025-2026 period.
Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased securities between August 4, 2025, and July 29, 2026. The filing alleges that the company issued misleading statements regarding its business operations and financial health during this timeframe.
The lawsuit argues that investors suffered financial losses due to stock price fluctuations linked to disclosures made throughout the class period. The legal action seeks to recover damages for those affected by the alleged securities violations.
Interested parties must submit their applications to serve as lead plaintiffs by the November 2, 2026, deadline. This procedural step allows the court to appoint representatives to manage the litigation on behalf of the affected shareholder group.